Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors for the purchase of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting fees and expenses.
The offering is set to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million.
Closing Date
Set for August 15, 2025.
- The offering provides additional funds for Scienture Holdings, Inc. to support its operations and upcoming ventures.
- The successful completion of the offering enhances the capital structure of the company.
The registered direct offering represents a strategic move by Scienture Holdings, Inc. to strengthen its financial position and support the development of novel pharmaceutical products.